| Title |
Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
|
Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
|
Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
|
| CMS eCQM ID |
CMS129v10
|
CMS129v11
|
CMS129v12
|
| NQF Number |
0389e
|
0389e
|
0389e
|
| Description |
Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer
|
Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer
|
Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer
|
| Initial Population |
All patients, regardless of age, with a diagnosis of prostate cancer
|
All patients, regardless of age, with a diagnosis of prostate cancer
|
All patients, regardless of age, with a diagnosis of prostate cancer
|
| Denominator |
Equals Initial Population at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy
|
Equals Initial Population at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy
|
Equals Initial Population at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy
|
| Denominator Exclusions |
None
|
None
|
None
|
| Numerator |
Patients who did not have a bone scan performed at any time since diagnosis of prostate cancer
|
Patients who did not have a bone scan performed at any time since diagnosis of prostate cancer
|
Patients who did not have a bone scan performed at any time since diagnosis of prostate cancer
|
| Numerator Exclusions |
Not Applicable
|
Not Applicable
|
Not Applicable
|
| Denominator Exceptions |
Documentation of reason(s) for performing a bone scan (including documented pain, salvage therapy, other medical reasons, bone scan ordered by someone other than reporting physician)
|
Documentation of reason(s) for performing a bone scan (including documented pain, salvage therapy, other medical reasons, or bone scan ordered by someone other than reporting clinician)
|
Documentation of reason(s) for performing a bone scan (including documented pain, salvage therapy, other medical reasons, or bone scan ordered by someone other than reporting clinician)
|
| Measure Steward |
PCPI(R) Foundation (PCPI[R])
|
Centers for Medicare & Medicaid Services (CMS)
|
Centers for Medicare & Medicaid Services (CMS)
|
| Measure Scoring |
Proportion measure
|
Proportion measure
|
Proportion measure
|
| Measure Type |
Process measure
|
Process measure
|
Process measure
|
| Improvement Notation |
Higher score indicates better quality
|
Higher score indicates better quality
|
Higher score indicates better quality
|
| Guidance |
A higher score indicates appropriate treatment of patients with prostate cancer at low (or very low) risk of recurrence. Only patients with prostate cancer with low (or very low) risk of recurrence will be counted in the performance denominator of this measure.
This eCQM is a patient-based measure.
This version of the eCQM uses QDM version 5.5. Please refer to the eCQI resource center for more information on the QDM.
|
A higher score indicates appropriate treatment of patients with prostate cancer at low (or very low) risk of recurrence. Only patients with prostate cancer with low (or very low) risk of recurrence will be counted in the performance denominator of this measure.
This eCQM is a patient-based measure.
Telehealth encounters are not eligible for this measure because the measure does not contain telehealth-eligible codes.
This version of the eCQM uses QDM version 5.5. Please refer to the eCQI resource center for more information on the QDM.
|
A higher score indicates appropriate treatment of patients with prostate cancer at low (or very low) risk of recurrence. Only patients with prostate cancer with low (or very low) risk of recurrence will be counted in the performance denominator of this measure.
This eCQM is a patient-based measure.
Telehealth encounters are not eligible for this measure because the measure does not contain telehealth-eligible codes.
This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM.
|
| MIPS Quality ID |
102
|
102
|
102
|
| Telehealth Eligible |
No
|
No
|
No
|
| Next Version |
CMS129v11
|
CMS129v12
|
No Version Available
|
| Previous Version |
No Version Available
|
|
|